Jason Springs is currently the CEO of GeneWeave Biosciences, LLC. His company develops diagnostic devices that detect the presence and drug-resistance of disease-causing bacteria without the need for a diagnostic laboratory. The company is particularly focused on detecting so-called "superbugs" -disease-causing bacteria that are resistant or immune to standard antibiotics, as well as bacteria responsible for many hospital-acquired infections (HAIs).
Jason Springs is a first year MBA student at the Johnson School at Cornell University. He received his undergraduate degree in Economics and Management from the University of South Carolina.
Right now we're looking at raising some seed capital, just some initial investment, around $400,000. This purchases lab equipment, microbiology lab equipment, some consulting services, we need to hire couple of development engineers, and finish up some pre-clinical tests in the lab just to make sur...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login